GLP-1 agonists like semaglutide and tirzepatide are peptide hormones that activate GLP-1 receptors on pancreatic and gastrointestinal cells
This analysis uses data from several sources, including two Center surveys conducted in 2024 and 2025
may be prescribed off-label) Ro does NOT offer compounded GLP-1 alternatives according to publicly available information
Weight loss is the most visible change, with clinical trials demonstrating average reductions that vary by medication: approximately 5-10% with liraglutide (Saxenda), 15-17% with semaglutide 2.4mg (Wegovy) in the STEP trials, and up to 20% with higher doses of tirzepatide in the SURMOUNT programme
L-Carnitine (Carnipure) (from 746 mg L-Carnitine Tartrate), Bulking Agent (Microcrystalline Cellulose), Hypromellose (Cellulose Capsule), Anti-Caking Agent (Magnesium Stearate (Vegetable Source)), Anti-Caking Agent (Silicon Dioxide) Take 2 capsules 1 to 3 times daily